CPHI, PMEC India scheduled for November

The 18th edition of CPHI and PMEC India 2025 is scheduled from 25 to 27 November 2025, at the India Expo Mart, Greater Noida, Delhi-NCR. Organised by Informa Markets in India, CPHI and PMEC India will bring together over 2,000 exhibitors and 50,000+ industry professionals, buyers, and investors from 120+ countries.

Yogesh Mudras, managing director of Informa Markets in India, said, "The sector continues to play a pivotal role in driving economic growth and global healthcare accessibility by contributing around 1.72% to the national GDP. With the Union Budget 2025–26 proposing an allocation of over INR 5,268-crore to the Department of Pharmaceuticals, marking a nearly 29% increase from the previous year, the government's continued focus on strengthening R&D, infrastructure, and capacity building further reinforces India's vision of becoming a global hub for pharmaceutical innovation.” 

As India's pharmaceutical industry gears up for robust expansion, the sector's total market size is projected to reach USD 130-billion by 2030 and USD 450-billion by 2047, highlighting the country's growing role as a global pharmaceutical powerhouse. The upcoming edition will focus on key industry themes such as API self-reliance, sustainability, digitalisation, and exports, highlighting India's transition toward innovation-driven growth. The event will showcase solutions in clean manufacturing, ESG compliance, and Pharma 4.0 technologies, aligning with the evolving needs of a future-ready pharma ecosystem. Visitors can expect exciting product launches and breakthrough technology innovations, highlighting India's growing capability in sustainable and high-value pharma manufacturing.

CPHI and PMEC India 2025 will welcome international exhibitors from China, Italy, Germany, Switzerland, and South Korea, among others, strengthening cross-border collaborations and export opportunities. This year's edition will also host attendee-favoured events like the Pharma Leaders Roundtable, the Women in Pharma Roundtable, the CPHI Pharma Awards, and the Pharma Connect Congress, offering a platform for policy dialogues, leadership exchange, and innovation-driven discussions.

Additionally, the three-day event will also feature a comprehensive line-up of knowledge-led conferences and leadership dialogues, designed to drive strategic discussions and actionable insights for the pharmaceutical community. Key sessions will explore themes such as business sustainability in a shifting geopolitical landscape, reimagining innovation and manufacturing to enable transformative and affordable medicines, and enhancing patient centricity beyond GMP compliance. Further, high-level panels will delve into charting the roadmap to meet sustainability goals and incorporating green design principles in pharma packaging and logistics to reduce carbon footprint, reflecting the industry's collective vision towards responsible growth, innovation, and global competitiveness.

The event will see participation from exhibitors such as Dr Reddy's Laboratories, Hetero Labs, Oceanic Pharmachem, Akums Drugs and Pharmaceuticals, Morepen Laboratories, MSN Laboratories, Capsugel Healthcare, Biocon, and Jubilant Ingrevia. On the machinery side, PMEC India will feature players including ACG Pam Pharma Technologies, Cadmach Machinery, Ace Technologies and Packaging Systems, Parle Global Technologies, Klenzaids Contamination Controls, Gansons, Elmach Packages India, Shimadzu India, and Snowbell Machines.

Supported by industry associations such as Pharmexcil, International Pharmaceutical Excipients Council (IPEC) India, Bulk Drug Manufacturers Association of India (BDMAI), Organisation of Pharmaceutical Producers of India (OPPI), Federation of Pharma Entrepreneurs (FOPE) and The Indian Pharmaceutical Association (IPA), along with participation from regulatory authorities and policymakers. 

The exhibit profile and focus on innovation at CPHI and PMEC India 2025 aim to strengthen India's role as the pharmacy of the world, fostering meaningful partnerships and charting the next phase of growth for the pharmaceutical industry.